PharmaBoardroom

Hansoh IPO Raises $1 Billion on Hong Kong Exchange

The company sold 551 million shares in the latest IPO on the Hong Kong Exchange and plans to invest half of its earnings in R&D. Hong Kong is now…

European MidPharmas: Focused and Resilient, yet Vulnerable

European MidPharmas – R&D based pharmaceutical companies with annual revenues of between EUR 50 million and 5 billion – are having to be…

José Herraez – General Manager, Beckman Coulter Iberia

José Herraez, general manager of Beckman Coulter in Iberia, sheds light on the special features of the Danaher business model, and how that has aided…

Jesús Donado – CEO, B. Braun Spain

Jesús Donado, CEO of B. Braun Spain introduces the company’s strong footprint in Spain, as a manufacturing hub and a global centre of excellence…

New France Pharma Report June 2019 Out Now

The latest issue of Healthcare & Life Sciences Review France follows on from our March 2019 report and takes a closer look at the wider French…

Margarita Alfonsel – General Secretary, Fenin, Spain

Margarita Alfonsel, general secretary of Fenin, offers her perspective on the state of the MedTech industry in Spain, the changing dynamics between…

Esteve: Out with the Old; In with the New

Esteve has long been a family-run business, though in early 2018 the Spanish champion decided to make a daring, though calculated, move and positioned…

Servier’s Olivier Laureau: Change Instigator

Not long ago, Laboratories Servier was considered a somewhat mysterious and opaque actor on the world pharmaceuticals stage. Privately owned, smaller…

China: Driving Big Pharma’s Sales Growth for the Long Term?

China is a hot topic in Big Pharma investor updates these days. The world’s second-largest pharmaceutical market boasts sales growth that…

Spanish Mid-Caps: Going Global

Despite the Spanish economy and pharmaceutical market’s steady growth, many local players are becoming cognizant of the limitations and risks of…

Pierre Fabre: Medicalization, Convergence & the Rise of…

Iconic French skincare specialist, Pierre Fabre has been enjoying a hot streak of late, with its dermo-cosmetics business registering hefty sales…

Forging a New Path to Commercialization for Cell and Gene…

Greg Reh comments on the panel discussion from the Financial Times US Pharma and Biotech Summit about the changes needed to face coming innovations in…

Tagged with P